Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People?

Authors

  • David J. Stott MD,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Alison Falconer MRCP,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Gillian D. Kerr MRCP,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Heather M. Murray MSc,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Stella Trompet MSc,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Rudi G. J. Westendorp PhD,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Brendan Buckley FRCPI,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Anton J. M. De Craen PhD,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Naveed Sattar PhD,

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author
  • Ian Ford PhD

    1. From the *Academic Section of Geriatric Medicine, Faculty of MedicineRobertson Centre for BiostatisticsDepartment of Vascular Biochemistry, University of Glasgow, Glasgow, United KingdomDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands§Department of Pharmacology and Therapeutics, Cork University Hospital, Cork, Ireland.
    Search for more papers by this author

Address correspondence to Professor David J. Stott, Academic Section of Geriatric Medicine, 3rd Floor Queen Elizabeth Building, Royal Infirmary, Glasgow G31 2ER, United Kingdom. E-mail: d.j.stott@clinmed.gla.ac.uk

Abstract

OBJECTIVES: To determine whether low to moderate alcohol intake is protective against cognitive decline in older people.

DESIGN: Prospective cohort study.

SETTING: Community-based study in Ireland, the Netherlands, and Scotland.

PARTICIPANTS: Five thousand eight hundred four people (3,000 women) aged 70 to 82 and randomized to pravastatin or placebo in the Prospective Study of Pravastatin in the Elderly at Risk.

MEASUREMENTS: Alcohol consumption was determined at study baseline. Serial measures of cognitive function over 3.2 years mean follow-up included Mini-Mental-State-Examination (MMSE), speed of information processing (Stroop and Letter-Digit Coding tests), and immediate and delayed memory (Picture-Word Learning test).

RESULTS: Forty-two percent of women and 71% of men were alcohol drinkers. Cognitive performance was better for female drinkers than nondrinkers for all cognitive domains over the 3.2-year follow-up; no significant effects were seen for men (linear mixed model, including adjusting for possible confounders). The rate of cognitive decline was similar for drinkers and nondrinkers for all cognitive domains, except for MMSE, which declined significantly less in female drinkers than nondrinkers (linear mixed model attenuated rate of decline=0.05 MMSE units per annum, P=.001).

CONCLUSION: Drinking low to moderate amounts of alcohol may delay age-associated cognitive decline in older women (including slowing deterioration in global cognitive function), but these apparent benefits were not clearly seen in older men.

Ancillary